Not soon. The earnings look like a mature industrial, so the multiple is low. It will take a big development to goose earnings for a couple of years and boost the earnings. I. personally, thought use of CRT in heart failure would be that big, but somehow it hasn't paid. Maybe closed-loop blood sugar control.
Could have bought BSX and still be under water. Luck of the draw.
You saved a bundle and even though BSX has received good news lately, I don't think the bad news is over yet.
The City of Roseville Employees’ Retirement system has filed suit against Boston Scientific (BSX), alleging the medical device company misled investors over its business prospects for its cardiac rhythm management business, Reuters reported. The suit, which seeks class action status for investors who bought Boston Scientific shares from April 20, 2009 through March 12, 2010, charges the company made false statements and failed to disclose material facts regarding risks to its business, causing the stock to trade at artificially inflated prices. It said the company misled investors when it claimed its cardiac rhythm device business had stabilized after the 2006 acquisition of Guidant and was set to grow with the introduction of new products.